Skip to main content

Protalix Biotherapeutics (NY: PLX )

1.160 UNCHANGED
Official Closing Price Updated: 6:30 PM EST, Nov 8, 2024 Add to My Watchlist

Other Filings

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Form 8-K
Source: SEC/Edgar
January 03, 2011
Form CT ORDER
Source: SEC/Edgar
December 06, 2010
Form 8-K
Source: SEC/Edgar
November 28, 2010
Form 8-K
Source: SEC/Edgar
November 09, 2010
Form 8-K
Source: SEC/Edgar
November 01, 2010
Form 8-K
Source: SEC/Edgar
October 24, 2010
Form ARS
Source: SEC/Edgar
October 06, 2010
Form DEF 14A
Source: SEC/Edgar
October 03, 2010
Form 8-K
Source: SEC/Edgar
September 12, 2010
Form 8-K
Source: SEC/Edgar
September 06, 2010
Form 8-K
Source: SEC/Edgar
August 29, 2010
Form 8-K
Source: SEC/Edgar
August 15, 2010
Form 8-K
Source: SEC/Edgar
July 12, 2010
Form 8-K
Source: SEC/Edgar
July 11, 2010
Form 8-K
Source: SEC/Edgar
June 07, 2010
Form 8-K
Source: SEC/Edgar
May 17, 2010
Form 8-K
Source: SEC/Edgar
April 26, 2010
Form 8-K
Source: SEC/Edgar
March 16, 2010
Form CT ORDER
Source: SEC/Edgar
March 14, 2010
Form 8-K
Source: SEC/Edgar
March 08, 2010
Form 8-K
Source: SEC/Edgar
March 02, 2010
Form SC 13G
Source: SEC/Edgar
February 15, 2010
Form 8-K
Source: SEC/Edgar
February 10, 2010
Form 8-K
Source: SEC/Edgar
February 04, 2010
Form 8-K
Source: SEC/Edgar
February 01, 2010
Form 8-K
Source: SEC/Edgar
January 13, 2010
Form 8-K
Source: SEC/Edgar
December 21, 2009
Form 8-K
Source: SEC/Edgar
December 09, 2009
Form 8-K
Source: SEC/Edgar
November 30, 2009
Form 8-K/A
Source: SEC/Edgar
October 14, 2009
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
15 16 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.